QIAGEN N.V. (QIA.DE) Stock Fundamental Analysis
Europe - FRA:QIA - NL0015002CX3 - Common Stock
38.45 EUR
-0.43 (-1.12%)
QIA gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 19 industry peers in the Life Sciences Tools & Services industry. QIA scores excellent points on both the profitability and health parts. This is a solid base for a good stock. QIA has a decent growth rate and is not valued too expensively. With these ratings, QIA could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
In the past year QIA was profitable.
In the past year QIA had a positive cash flow from operations.
In the past 5 years QIA has always been profitable.
Each year in the past 5 years QIA had a positive operating cash flow.
1.2 Ratios
QIA has a Return On Assets of 6.41%. This is in the better half of the industry: QIA outperforms 78.95% of its industry peers.
With a decent Return On Equity value of 10.65%, QIA is doing good in the industry, outperforming 78.95% of the companies in the same industry.
QIA's Return On Invested Capital of 8.66% is fine compared to the rest of the industry. QIA outperforms 73.68% of its industry peers.
QIA had an Average Return On Invested Capital over the past 3 years of 7.25%. This is in line with the industry average of 7.19%.
The 3 year average ROIC (7.25%) for QIA is below the current ROIC(8.66%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.41% | ||
| ROE | 10.65% | ||
| ROIC | 8.66% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
1.3 Margins
QIA has a better Profit Margin (18.30%) than 94.74% of its industry peers.
In the last couple of years the Profit Margin of QIA has declined.
QIA has a Operating Margin of 26.86%. This is amongst the best in the industry. QIA outperforms 100.00% of its industry peers.
In the last couple of years the Operating Margin of QIA has grown nicely.
Looking at the Gross Margin, with a value of 64.18%, QIA belongs to the top of the industry, outperforming 94.74% of the companies in the same industry.
In the last couple of years the Gross Margin of QIA has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.86% | ||
| PM (TTM) | 18.3% | ||
| GM | 64.18% |
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), QIA is creating some value.
Compared to 1 year ago, QIA has less shares outstanding
Compared to 5 years ago, QIA has less shares outstanding
The debt/assets ratio for QIA has been reduced compared to a year ago.
2.2 Solvency
QIA has an Altman-Z score of 3.97. This indicates that QIA is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 3.97, QIA belongs to the best of the industry, outperforming 89.47% of the companies in the same industry.
QIA has a debt to FCF ratio of 2.91. This is a good value and a sign of high solvency as QIA would need 2.91 years to pay back of all of its debts.
QIA's Debt to FCF ratio of 2.91 is amongst the best of the industry. QIA outperforms 84.21% of its industry peers.
A Debt/Equity ratio of 0.25 indicates that QIA is not too dependend on debt financing.
QIA has a Debt to Equity ratio of 0.25. This is amongst the best in the industry. QIA outperforms 89.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 2.91 | ||
| Altman-Z | 3.97 |
ROIC/WACC1.13
WACC7.63%
2.3 Liquidity
QIA has a Current Ratio of 1.61. This is a normal value and indicates that QIA is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.61, QIA is doing good in the industry, outperforming 63.16% of the companies in the same industry.
QIA has a Quick Ratio of 1.35. This is a normal value and indicates that QIA is financially healthy and should not expect problems in meeting its short term obligations.
QIA has a better Quick ratio (1.35) than 73.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.61 | ||
| Quick Ratio | 1.35 |
3. Growth
3.1 Past
QIA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.20%, which is quite good.
QIA shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.40% yearly.
Looking at the last year, QIA shows a small growth in Revenue. The Revenue has grown by 5.15% in the last year.
The Revenue has been growing slightly by 5.32% on average over the past years.
EPS 1Y (TTM)12.2%
EPS 3Y-6.66%
EPS 5Y8.4%
EPS Q2Q%6.06%
Revenue 1Y (TTM)5.15%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%7.49%
3.2 Future
Based on estimates for the next years, QIA will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.02% on average per year.
QIA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.38% yearly.
EPS Next Y7.88%
EPS Next 2Y8.09%
EPS Next 3Y8.68%
EPS Next 5Y8.02%
Revenue Next Year5.25%
Revenue Next 2Y5.47%
Revenue Next 3Y5.89%
Revenue Next 5Y7.38%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 19.23, which indicates a rather expensive current valuation of QIA.
Compared to the rest of the industry, the Price/Earnings ratio of QIA indicates a somewhat cheap valuation: QIA is cheaper than 78.95% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.27, QIA is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 17.35, the valuation of QIA can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of QIA indicates a somewhat cheap valuation: QIA is cheaper than 78.95% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.77, QIA is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.23 | ||
| Fwd PE | 17.35 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, QIA is valued a bit cheaper than 63.16% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of QIA indicates a somewhat cheap valuation: QIA is cheaper than 73.68% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.7 | ||
| EV/EBITDA | 13.78 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates QIA does not grow enough to justify the current Price/Earnings ratio.
QIA has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.44
PEG (5Y)2.29
EPS Next 2Y8.09%
EPS Next 3Y8.68%
5. Dividend
5.1 Amount
With a yearly dividend of 0.54%, QIA is not a good candidate for dividend investing.
QIA's Dividend Yield is a higher than the industry average which is at 0.71.
Compared to an average S&P500 Dividend Yield of 2.38, QIA's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.54% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y8.09%
EPS Next 3Y8.68%
FRA:QIA (9/15/2025, 5:29:56 PM)
38.45
-0.43 (-1.12%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners87.24%
Inst Owner ChangeN/A
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap8.34B
Analysts75
Price Target44.59 (15.97%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.54% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.7%
Min EPS beat(2)-2.4%
Max EPS beat(2)7.8%
EPS beat(4)2
Avg EPS beat(4)1.23%
Min EPS beat(4)-3.85%
Max EPS beat(4)7.8%
EPS beat(8)5
Avg EPS beat(8)1.51%
EPS beat(12)8
Avg EPS beat(12)3.69%
EPS beat(16)12
Avg EPS beat(16)5.44%
Revenue beat(2)1
Avg Revenue beat(2)0.66%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)1.43%
Revenue beat(4)1
Avg Revenue beat(4)-0.16%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)1.43%
Revenue beat(8)1
Avg Revenue beat(8)-0.61%
Revenue beat(12)3
Avg Revenue beat(12)-0.41%
Revenue beat(16)7
Avg Revenue beat(16)0.85%
PT rev (1m)0.81%
PT rev (3m)0.14%
EPS NQ rev (1m)0.43%
EPS NQ rev (3m)0.96%
EPS NY rev (1m)0.08%
EPS NY rev (3m)0.53%
Revenue NQ rev (1m)0.17%
Revenue NQ rev (3m)2%
Revenue NY rev (1m)0.9%
Revenue NY rev (3m)1.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.23 | ||
| Fwd PE | 17.35 | ||
| P/S | 4.79 | ||
| P/FCF | 19.7 | ||
| P/OCF | 14.47 | ||
| P/B | 2.79 | ||
| P/tB | 15.28 | ||
| EV/EBITDA | 13.78 |
EPS(TTM)2
EY5.2%
EPS(NY)2.22
Fwd EY5.76%
FCF(TTM)1.95
FCFY5.08%
OCF(TTM)2.66
OCFY6.91%
SpS8.03
BVpS13.8
TBVpS2.52
PEG (NY)2.44
PEG (5Y)2.29
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.41% | ||
| ROE | 10.65% | ||
| ROCE | 11.67% | ||
| ROIC | 8.66% | ||
| ROICexc | 10.87% | ||
| ROICexgc | 46.44% | ||
| OM | 26.86% | ||
| PM (TTM) | 18.3% | ||
| GM | 64.18% | ||
| FCFM | 24.31% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
ROICexc(3y)9.42%
ROICexc(5y)10.13%
ROICexgc(3y)34.6%
ROICexgc(5y)42.77%
ROCE(3y)9.77%
ROCE(5y)10.73%
ROICexcg growth 3Y-31.24%
ROICexcg growth 5Y-2.41%
ROICexc growth 3Y-13.09%
ROICexc growth 5Y6.48%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
F-Score8
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 2.91 | ||
| Debt/EBITDA | 1.2 | ||
| Cap/Depr | 94.78% | ||
| Cap/Sales | 8.78% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 91.61% | ||
| Profit Quality | 132.83% | ||
| Current Ratio | 1.61 | ||
| Quick Ratio | 1.35 | ||
| Altman-Z | 3.97 |
F-Score8
WACC7.63%
ROIC/WACC1.13
Cap/Depr(3y)78.4%
Cap/Depr(5y)95.94%
Cap/Sales(3y)7.97%
Cap/Sales(5y)9.87%
Profit Quality(3y)273.85%
Profit Quality(5y)189.74%
High Growth Momentum
Growth
EPS 1Y (TTM)12.2%
EPS 3Y-6.66%
EPS 5Y8.4%
EPS Q2Q%6.06%
EPS Next Y7.88%
EPS Next 2Y8.09%
EPS Next 3Y8.68%
EPS Next 5Y8.02%
Revenue 1Y (TTM)5.15%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%7.49%
Revenue Next Year5.25%
Revenue Next 2Y5.47%
Revenue Next 3Y5.89%
Revenue Next 5Y7.38%
EBIT growth 1Y21.82%
EBIT growth 3Y-9.05%
EBIT growth 5Y9.63%
EBIT Next Year57.21%
EBIT Next 3Y22.62%
EBIT Next 5Y14.77%
FCF growth 1Y31.74%
FCF growth 3Y5.12%
FCF growth 5Y55.1%
OCF growth 1Y29.99%
OCF growth 3Y1.77%
OCF growth 5Y15.28%